Overview
Insight Economics has been retained by generic drug companies looking to introduce new products. Generic companies may need assistance determining if the resources needed to develop a product are outweighed by the profits they could potentially retain.

Challenge
The number of competitors, market size, litigation risk, product type, and patent terms can all play a role in determining the profits the generic company could potentially retain. Literature in the field of generic drug introductions is extensive which allows for detailed financial modeling.  

Results
Insight advised multiple generic companies which ultimately made significant sales in the market. The research in the generic industry was detailed and allowed for a mitigation of risk for the generic drug sales. Eventually, the generic drug companies made significant sales and highly penetrated the market.